Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Minimal Access vs. Open Spine Surgery in Patients With Metastatic Spinal Cord Compression - A One-Center Randomized Controlled Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term Survival After Surgical Treatment of Spinal Metastasis - The Predictive Role of Sex

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Improving Photoprotection and Implications for 25(OH)D Formation

    Research output: Contribution to journalReviewResearchpeer-review

  5. Lifetime UVR Dose and Skin Cancer Risk, Determined by Their Common Relation to Solar Lentigines

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND/AIM: Ovarian cancer (OC) is the 5th most common cancer among European women. Approximately 70-80% of OC is diagnosed at advanced stage resulting in an elevated mortality rate. The aim of this study was to examine whether Annexin A2 and S100A10 expression can be used as prognostic markers for epithelial ovarian cancer (EOC).

MATERIALS AND METHODS: Expression of Annexin A2 and S100A10 was evaluated in EOC tissue samples (n=303) by immunohistochemistry. The staining of the membrane, cytoplasmic and stroma was assessed according to intensity.

RESULTS: The expression of both markers correlated to histological subtype, histological grading, International Federation of Gynecology and Obstetrics (FIGO) stage, and macro-radical surgery. Univariate Cox regression analysis showed that Annexin A2 and S100A10 in stromal tissue correlated with shorter overall survival (OS). Multivariate Cox regression analysis demonstrated no independent prognostic significance of stromal Annexin A2 expression.

CONCLUSION: High expression of Annexin A2 and S100A10 in stromal tissue from EOC patients was associated with reduced OS; however, no independent prognostic value was found for any of the markers.

Original languageEnglish
JournalAnticancer Research
Volume39
Issue number5
Pages (from-to)2475-2482
Number of pages8
ISSN0250-7005
DOIs
Publication statusPublished - May 2019

    Research areas

  • Aged, Annexin A2/genetics, Biomarkers, Tumor/genetics, Carcinoma, Ovarian Epithelial/genetics, Female, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Middle Aged, Prognosis, S100 Proteins/genetics

ID: 59089752